Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease based » disease based (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
mean decrease » a decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease based » disease based (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
mean decrease » a decrease (Expand Search)
-
81
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
82
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
83
-
84
Trends in the observed total annual rainfall and mean temperature over Taita Taveta (1981–2020).
Published 2023Subjects: -
85
-
86
-
87
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
88
-
89
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
90
-
91
-
92
-
93
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
94
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
95
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
96
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
97
-
98
-
99
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
100